Christian Buske, MD¹, Efstathios Kastritis, MD, PhD^2*, Alexander Grunenberg, MD^3*, Andreas Viardot, MD, PhD³, Dajana Kaczynski^1*, Heike Mund^4*, Katja Gutmair^5*, Matthias Zingerle^6*, Paul Duewel^7*, Susanne Saussele, MD⁸, Björn Schöttker^9*, Ullrich Graeven, MD^10*, Martin Dreyling, MD¹¹, Andrea Kerkhoff, MD^12*, Thomas Weber^13*, Holger F. Hebart, MD¹⁴, Ralf Ulrich Trappe, MD^15*, Lisa Kaiser^1*, Elke Runge^1*, Jasmin Mark^1*, Simone Ferrero, MD¹⁶, Daniela Drandi^17*, Falko Fend, MD^18*, Irina Bonzheim^19*, Eva Hoster, PhD, Prof.^20*, Jens Dreyhaupt^21* and Meletios A. Dimopoulos, MD²

¹Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany
²Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
⁴University Hospital Ulm, Ulm, Germany
⁵Institute of Medical Information, University of Munich, Munich, Germany
⁶Haematology and Oncology, Munich-Pasing MVZ GmbH,, Munich, Germany
⁷Oncological Specialist Practice, Studiengesellschaft Onkologie Bielefeld, Bielefeld, Germany
⁸Universitätsmedizin Mannheim, Ilvesheim, Germany
⁹Joint practice for Haematology and Internal Oncology, Wuerzburg, Germany
¹⁰Department of Hematology, Oncology and Gastroenterology, Medical Clinic I, Hospital Maria Hilf GmbH, Mönchengladbach, Germany, Mönchengladbach, DEU
¹¹Department of Internal Medicine 3, Ludwig-Maximilians-Universität (LMU), Munich, Germany
¹²Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
¹³Department of Internal Medicine IV, Haematology and Oncology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Germany
¹⁴Department of Internal Medicine, Hematology and Oncology, Stauferklinikum, Mutlangen, Mutlangen, Germany
¹⁵Department of Internal Medicine III, DIAKO Ev. Diakonie-Krankenhaus, Bremen, Germany
¹⁶Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, Torino, TO, Italy
¹⁷Hematology Division I, Department of Molecular Biotechnologies and Health Sciences, University of Turin/University Hospital A.O.U. “Città della Salute e della Scienza”, Torino, Italy, Italy
¹⁸University of Tübingen, Department of Pathology and Neuropathology, Tuebingen, Germany
¹⁹Institute of Pathology, Tuebingen, DEU
²⁰Institute of Medical Data Processing, Biometrics and Epidemiology (IBE), LMU Munich, Munich, Germany
²¹Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany

John F. Seymour, MBBS, PhD¹, Constantine S. Tam, MD, MBBS², Chan Y. Cheah, MBBS DMSc^3,4,5, Ricardo D. Parrondo, MD⁶, John N. Allan, MD⁷, Judith Trotman, FRACP⁸, Ranjana H. Advani, MD⁹, Herbert A. Eradat, MD¹⁰, Pier Luigi Zinzani, MD, PhD¹¹, Masa Lasica, MBBS, BMedSci, FRACP, FRCPA^12*, Steven P. Treon, MD, PhD, FRCP¹³, Xiangmei Chen^14*, Kunthel By, PhD^15*, Shannon Fabre^15*, Daniel O. Persky, MD¹⁵, Amit Agarwal^15* and Anna Maria Frustaci, MD^16*

¹Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
²Alfred Hospital and Monash University, Melbourne, VIC, Australia
³Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
⁴Medical School, University of Western Australia, Perth, Western Australia, Australia
⁵Linear Clinical Research, Nedlands, Western Australia, Australia
⁶Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
⁷Division of Hematology and Oncology, Weill Cornell Medicine, Long Island City, NY
⁸Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia
⁹Stanford Cancer Institute, Stanford, CA
¹⁰David Geffen School of Medicine at UCLA, Los Angeles, CA
¹¹Institute of Hematology "Seràgnoli", University of Bologna, Bologne, Italy
¹²St Vincent’s Hospital, Melbourne, Australia
¹³Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹⁴BeiGene (Shanghai) Co, Ltd, Shanghai, China
¹⁵BeiGene USA, Inc, San Mateo, CA
¹⁶ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

Sikander Ailawadhi, MD¹, Maria Gavriatopoulou^2*, Jennifer Peterson, MD^3*, Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc^4*, Ghassan El-Haddad^5*, Ariel Grajales-Cruz^6*, Aimaz Afrough^7*, Moshe Y. Levy^8*, Judith Trotman, FRACP⁹, Kimberly R. Doucette^10*, Jorge J. Castillo, MD¹¹, Francisco Hernandez-Ilizaliturri, MD¹², Ajay K. Nooka^13*, Shirley D'Sa, MD(Res)^14*, Ralph V. Boccia^15*, Harsh Parmar, MD¹⁶, Carlos Fernández de Larrea, MD¹⁷, Guldane Cengiz Seval^18*, Luiza Beatriz Goncalves Beber^19*, Radhakrishnan Ramchandren, MD^20*, Sheeba K. Thomas, MD²¹, Jarrod Longcor^22*, Andrei Shustov^22* and Larry D Anderson Jr., MD, PhD²³

¹Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
²Alexandra General Hospital, Athens, Greece
³Mayo Clinic, Jacksonville
⁴Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁵Moffitt Cancer Center, Tampa, FL
⁶Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa
⁷UT Southwestern Simmons Cancer Center, Dallas, TX
⁸Texas Oncology, Dallas, TX
⁹University of Sydney, Concord Repatriation General Hospital, Concord, Australia
¹⁰MedStar Georgetown University Hospital, Washington, DC
¹¹Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
¹²Department of Medicine (Lymphoma Section), Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹³Emory Winship Cancer Institute, Atlanta, GA
¹⁴University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁵Center for Cancer and Blood Disorders, Bethesda, MD
¹⁶Division of Multiple Myeloma, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
¹⁷Hosp. Clinic I Provincial de Barcelona, Barcelona, Spain
¹⁸Ankara University Faculty of Medicine Cebeci Hospital, Ankara, Turkey
¹⁹Clinica de Oncologia Reichow, Blumenau, AL, BRA
²⁰University of Tennessee Cancer Institute, Knoxville, TN
²¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²²Cellectar Biosciences, Florham Park, NJ
²³Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX

Tae Min Kim, MD, PhD^1*, Seok-Goo Cho^2*, Michal Taszner^3*, Geoffrey Chong⁴, Jingxian Cai^5*, Amulya Uppala^5*, Aafia Chaudhry⁵, Hesham Mohamed⁵, Srikanth Ambati⁵ and John N. Allan, MD⁶

¹Seoul National University Hospital, Seoul, Korea, Republic of (South)
²Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
³Medical University of Gdańsk, Gdańsk, Poland
⁴Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital, Heidelberg, VIC, Australia
⁵Regeneron Pharmaceuticals, Inc., Tarrytown, NY
⁶Division of Hematology and Oncology, Weill Cornell Medicine, Long Island City, NY

Robert J. Kreitman, MD¹, Hao-Wei Wang, MD, PhD^2*, Dana I. Delgado Colon, MD^2*, Hong Zhou, BS^1*, Evgeny Arons, PhD^1*, Mark Raffeld, MD^2*, Liqiang Xi, MD^2*, Julie Feurtado, RN^3*, Lacey James, CRNP^1*, Raul C. Braylan, MD⁴, Katherine R. Calvo, MD, PhD⁴, Irina Maric, MD, MSc⁴ and Constance M. Yuan, MD, PhD^2*

¹Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD
³Office of Research Nursing, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁴Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD

Sattva S. Neelapu, MD¹, Julio C. Chavez, MD², Alison R. Sehgal, MD³, Narendranath Epperla, MD MS⁴, Matthew Ulrickson, MD⁵, Emmanuel Bachy, MD, PhD⁶, Pashna N. Munshi, MD⁷, Carla Casulo, MD⁸, David G. Maloney, MD, PhD⁹, Sven de Vos, MD, PhD^10*, Ran Reshef, MD, MSc¹¹, Lori A. Leslie, MD^12*, Olalekan O. Oluwole, MD, MPH, MBBS¹³, Ibrahim Yakoub-Agha, MD, PhD^14*, Rashmi Khanal, MD¹⁵, Joseph D. Rosenblatt, MD^16*, Jacob Wulff, DrPH^17*, Rhine Shen, PhD^17*, Wangshu Zhang, PhD^17*, Soumya Poddar^17*, Harry Miao, MD, PhD¹⁷, Olga Nikolajeva, MD^17* and Caron A. Jacobson, MD, MMSc¹⁸

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³UPMC Hillman Cancer Center, Pittsburgh, PA
⁴The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁵Banner MD Anderson Cancer Center, Gilbert, AZ
⁶Centre Hospitalier Lyon Sud, Pierre-Bénite, France
⁷Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁸Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
⁹Fred Hutchinson Cancer Center, Seattle, WA
¹⁰Ronald Reagan University of California Los Angeles Medical Center, Santa Monica, CA
¹¹Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
¹²John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
¹³Vanderbilt University Medical Center, Nashville, TN
¹⁴CHU de Lille, Université de Lille, INSERM U1286, Infinite, 59000, Lille, France
¹⁵Fox Chase Cancer Center, Philadelphia, PA
¹⁶University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
¹⁷Kite, a Gilead Company, Santa Monica, CA
¹⁸Dana-Farber Cancer Institute, Boston, MA